J&J, Evotec collaborate to research, develop Alzheimer's treatments
This article was originally published in Scrip
Executive Summary
Johnson & Johnson and Evotec are collaborating to research potential treatments for Alzheimer’s by studying genetic characteristics of the debilitating disease.